Iron Triangle Partners LP Acquires Shares of 250,000 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Iron Triangle Partners LP bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 250,000 shares of the exchange traded fund’s stock, valued at approximately $22,515,000. SPDR S&P Biotech ETF comprises 2.5% of Iron Triangle Partners LP’s holdings, making the stock its 17th largest holding. Iron Triangle Partners LP owned approximately 0.33% of SPDR S&P Biotech ETF at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Focus Partners Wealth grew its position in SPDR S&P Biotech ETF by 43.3% during the fourth quarter. Focus Partners Wealth now owns 38,038 shares of the exchange traded fund’s stock valued at $3,433,000 after buying an additional 11,491 shares during the period. Dimension Capital Management LLC boosted its stake in SPDR S&P Biotech ETF by 4.6% in the fourth quarter. Dimension Capital Management LLC now owns 17,287 shares of the exchange traded fund’s stock valued at $1,557,000 after acquiring an additional 767 shares during the last quarter. EP Wealth Advisors LLC grew its position in shares of SPDR S&P Biotech ETF by 10.3% during the 4th quarter. EP Wealth Advisors LLC now owns 5,533 shares of the exchange traded fund’s stock valued at $498,000 after acquiring an additional 518 shares during the period. EPG Wealth Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 37.5% during the 4th quarter. EPG Wealth Management LLC now owns 916 shares of the exchange traded fund’s stock worth $83,000 after purchasing an additional 250 shares during the last quarter. Finally, Blackstone Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 107.6% in the 4th quarter. Blackstone Inc. now owns 211,840 shares of the exchange traded fund’s stock worth $19,078,000 after purchasing an additional 109,810 shares during the period.

SPDR S&P Biotech ETF Trading Down 2.1 %

SPDR S&P Biotech ETF stock opened at $76.39 on Friday. The business’s 50 day simple moving average is $80.77 and its 200 day simple moving average is $89.22. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $105.47. The company has a market cap of $4.85 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.